Business
Oncothyreon announces November 6th webcast of third quarter 2008 financial results and corporate update conference call
SEATTLE, Nov. 3 /CNW/ - Oncothyreon Inc. (Nasdaq: ONTY) (TSX:ONY), a biotechnology company specia...

About this update from Cascade Copper Corp.
[{"type":"text","content":"\n\n\n\nSEATTLE, Nov. 3 /CNW/ - Oncothyreon Inc. (Nasdaq: ONTY) (TSX:ONY), a\nbiotechnology company specializing in the development of innovative\ntherapeutic products for the treatment of cancer, today announced that it\nintends to release its third quarter financial results on Thursday,\nNovember 6, 2008 after the close of the U.S. and Canadian markets. Following\nthe release, Oncothyreon's management expects to discuss these financial\nresults and give a general business update in a conference call at 4:30 p.m.\nEST.\n\n\nThe discussion is planned for a live webcast and can be accessed at\nwww.oncothyreon.com under the "News & Events" section. It is expected that the\narchive of the webcast will be available approximately one hour after\ncompletion of the discussion and will be posted on the Oncothyreon website for\n30 days.\n\n\nAbout Oncothyreon\n\n\nOncothyreon is a biotechnology company specializing in the development of\ninnovative therapeutic products for the treatment of cancer. Oncothyreon's\ngoal is to develop and commercialize novel synthetic vaccines and targeted\nsmall molecules that have the potential to improve the lives and outcomes of\ncancer patients. For more information, visit www.oncothyreon.com.\n\n\n","length":1298,"tagName":"div"}]